Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 145Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Lymphoma, Large B-Cell, Diffuse 89Leukemia 74Lymphoma, Non-Hodgkin 60Lymphoma, Follicular 47Burkitt Lymphoma 46Lymphoma, Mantle-Cell 43Hodgkin Disease 31Neuroblastoma 30Central Nervous System Neoplasms 29Sarcoma 24Lymphoma, Large-Cell, Immunoblastic 23Lymphoma, Large-Cell, Anaplastic 21Multiple Myeloma 19Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, B-Cell, Marginal Zone 15HIV Infections 15Brain Neoplasms 15Medulloblastoma 11Dendritic Cell Sarcoma, Interdigitating 11Astrocytoma 11Acquired Immunodeficiency Syndrome 11Wilms Tumor 10Rhabdomyosarcoma 10Lymphoma, T-Cell, Peripheral 10Lymphoma, B-Cell 10Recurrence 9Oligodendroglioma 9Neuroectodermal Tumors, Primitive, Peripheral 9

Interventions

bryostatin 1 1Vincristine 1Bryostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × AIDS-related Diffuse Large Cell Lymphoma × Vincristine × Clear all
NCT00022555 2013-01-25

Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Lymphoid

AIDS-related Diffuse Large Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡